Marius Pharmaceuticals Announces Co-CEOs Himanshu H. Shah and Shalin Shah to Drive Growth ahead of Anticipated FDA Action of its Lead Asset, KYZATREX January 27, 2021 Marius Pharmaceuticals Submits New Drug Application to U.S. FDA for Next-generation Oral Testosterone Replacement Therapy in Male Patients with Hypogonadism.